Improved diagnostics and prognostics of lung cancer and metastases to the lungs
1 – 20 of 72
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Distinct microRNA Signature and Suppression of ZFP36L1 Define ASCL1-Positive Lung Adenocarcinoma
(
- Contribution to journal › Article
- 2023
-
Mark
Aggrecan accumulates at sites of increased pulmonary arterial pressure in idiopathic pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Treatment refractory arthritis and stroke – A case of infective endocarditis caused by Tropheryma whipplei
(
- Contribution to journal › Article
-
Mark
Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases
2023) In Virchows Archiv(
- Contribution to journal › Article
-
Mark
Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Pulmonary 5-HT
2B receptor expression in fibrotic interstitial lung diseases.
(
- Contribution to journal › Article
-
Mark
Fibroblast subsets in non-small cell lung cancer : associations with survival, mutations, and immune features
(
- Contribution to journal › Article
-
Mark
Comparison of immunohistochemical mesothelial biomarkers in paired biopsies and effusion cytology cell blocks from pleural mesothelioma
(
- Contribution to journal › Article
-
Mark
Reference standards for gene fusion molecular assays on cytological samples : an international validation study
(
- Contribution to journal › Article
- 2022
-
Mark
Difficulties in diagnostics of lung tumours in biopsies : An interpathologist concordance study evaluating the international diagnostic guidelines
(
- Contribution to journal › Article
-
Mark
Genome-wide interaction analysis identified low-frequency variants with sex disparity in lung cancer risk
(
- Contribution to journal › Article
-
Mark
Iam hiQ-a novel pair of accuracy indices for imputed genotypes
(
- Contribution to journal › Article
-
Mark
Interventional and EBUS cytology in Sweden
(
- Contribution to journal › Scientific review
-
Mark
Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer
(
- Contribution to journal › Article
-
Mark
Feasibility of EBUS-TBNA for histopathological and molecular diagnostics of NSCLC-A retrospective single-center experience
(
- Contribution to journal › Article
-
Mark
PD‐L1 Expression in Non‐Small Cell Lung Cancer Specimens : Association with Clinicopathological Factors and Molecular Alterations
(
- Contribution to journal › Article
-
Mark
Ciliated (FOXJ1+) Cells Display Reduced Ferritin Light Chain in the Airways of Idiopathic Pulmonary Fibrosis Patients
(
- Contribution to journal › Article
- 2021
-
Mark
Integration of multiomic annotation data to prioritize and characterize inflammation and immune-related risk variants in squamous cell lung cancer
(
- Contribution to journal › Article
-
Mark
Evaluation of NTRK immunohistochemistry as a screening method for NTRK gene fusion detection in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
A gene expression-based single sample predictor of lung adenocarcinoma molecular subtype and prognosis
(
- Contribution to journal › Article